Suppr超能文献

SARS-CoV-2 nsp14 与 RNA 相互作用的弱结合及其光谱特征。

On the Weak Binding and Spectroscopic Signature of SARS-CoV-2 nsp14 Interaction with RNA.

机构信息

Department of Physical Chemistry, São Carlos Institute of Chemistry, University of São Paulo, Av. Trabalhador São Carlense, 400 - Parque Arnold Schimidt, São Carlos, SP, 13566-590, Brazil.

Biolinker, Av. Prof. Lineu Prestes, Cietec - Butantã, São Paulo, SP, 05508-000, Brazil.

出版信息

Chembiochem. 2021 Dec 10;22(24):3410-3413. doi: 10.1002/cbic.202100486. Epub 2021 Oct 14.

Abstract

The SARS-CoV-2 non-structural protein 14 (nsp14), known as exoribonuclease is encoded from the large polyprotein of viral genome and is a major constituent of the transcription replication complex (TRC) machinery of the viral RNA synthesis. This protein is highly conserved among the coronaviruses and is a potential target for the development of a therapeutic drug. Here, we report the SARS-CoV-2 nsp14 expression, show its structural characterization, and ss-RNA exonuclease activity through vibrational and electronic spectroscopies. The deconvolution of amide-I band in the FTIR spectrum of the protein revealed a composition of 35 % α-helix and 25 % β-sheets. The binding between protein and RNA is evidenced from the spectral changes in the amide-I region of the nsp14, showing protein conformational changes during the binding process. A value of 20.60±3.81 mol L of the binding constant (K ) is obtained for nsp14/RNA complex. The findings reported here can motivate further studies to develop structural models for better understanding the mechanism of exonuclease enzymes for correcting the viral genome and can help in the development of drugs against SARS-CoV-2.

摘要

严重急性呼吸综合征冠状病毒 2 非结构蛋白 14(nsp14),也称为核酸外切酶,由病毒基因组的大多聚蛋白编码,是病毒 RNA 合成的转录复制复合物(TRC)机制的主要组成部分。该蛋白在冠状病毒中高度保守,是开发治疗药物的潜在靶标。在这里,我们报告了严重急性呼吸综合征冠状病毒 2 nsp14 的表达情况,并通过振动和电子光谱法展示了其结构特征和 ss-RNA 外切酶活性。蛋白质的傅里叶变换红外光谱中酰胺-I 带的解卷积表明其由 35%的α-螺旋和 25%的β-折叠组成。nsp14 中酰胺-I 区域的光谱变化表明了蛋白质与 RNA 之间的结合,表明在结合过程中蛋白质构象发生了变化。nsp14/RNA 复合物的结合常数(K)值为 20.60±3.81 mol·L。这里报道的研究结果可以激励进一步的研究,以开发结构模型,从而更好地了解外切酶酶校正病毒基因组的机制,并有助于开发针对严重急性呼吸综合征冠状病毒 2 的药物。

相似文献

本文引用的文献

2
Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting.冠状病毒RNA校对:分子基础与治疗靶点
Mol Cell. 2020 Sep 3;79(5):710-727. doi: 10.1016/j.molcel.2020.07.027. Epub 2020 Aug 4.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验